APA aipamena

Yamano, Y., Takemura, M., Longshaw, C., & Echols, R. (2020). 1269. Differences in Interpretative Breakpoints Between CLSI, FDA and EUCAST Impact Reporting of Susceptibility and Resistance to Cefiderocol. Open Forum Infect Dis.

Chicago Style aipamena

Yamano, Yoshinori, Miki Takemura, Christopher Longshaw, and Roger Echols. "1269. Differences in Interpretative Breakpoints Between CLSI, FDA and EUCAST Impact Reporting of Susceptibility and Resistance to Cefiderocol." Open Forum Infect Dis 2020.

MLA aipamena

Yamano, Yoshinori, Miki Takemura, Christopher Longshaw, and Roger Echols. "1269. Differences in Interpretative Breakpoints Between CLSI, FDA and EUCAST Impact Reporting of Susceptibility and Resistance to Cefiderocol." Open Forum Infect Dis 2020.